Intravenous Infusion of High Dose Selenite in End-Stage Cancer Patients: Analysis of Systemic Exposure to Selenite and Seleno-Metabolites.

Breuer, Olof; Brodin, Ola; Razaghi, Ali; Brodin, David; Gammelgaard, Bente; Björnstedt, Mikael

Breuer, Olof; Brodin, Ola; Razaghi, Ali; Brodin, David; Gammelgaard, Bente; Björnstedt, Mikael.

Afiliação

Breuer O; Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital-Huddinge, SE-14186 Stockholm, Sweden.
Brodin O; Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Karolinska University Hospital-Huddinge, SE-14186 Stockholm, Sweden.
Razaghi A; Tema Cancer, Karolinska University Hospital-Solna, SE-14186, Stockholm, Sweden.
Brodin D; Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Karolinska University Hospital-Huddinge, SE-14186 Stockholm, Sweden.
Gammelgaard B; Department of Biosciences and Nutrition, Karolinska Institutet, SE-14183 Huddinge, Sweden.
Björnstedt M; Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark.

Biomedicines ; 11(2)2023 Jan 20.

Article em En | MEDLINE | ID: mdl-36830832

Palavras-chave

cancer; selenite; selenium; selenosugar; selenotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biomedicines Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google